NCT06962384Completed
Comparing Posterior Release Sclerotomy With Conventional Evisceration Surgery.
Comparative Analysis of Posterior Release Sclerotomy vs Conventional Ball Implantation in Evisceration Surgery
Source: ClinicalTrials.gov · Last updated 3 Jun 2025
Brief summary (registry, in English)
The primary objective of this interventional study is to compare posterior release sclerotomy in the scleral cup with conventional ball implantation during evisceration, focusing on intraoperative feasibility, postoperative outcomes, and implant stability. Specific objectives include: 1. Assessing the rate of implant migration and extrusion. 2. Evaluating the long-term stability of the implant within the scleral shell. 3. Investigating the occurrence of complications such as exposure or infection. 4. Analyzing the functional and anatomical outcomes. 5. Comparing patient satisfaction and quality of life measures.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 30 Apr 2025
- Start date
- 1 May 2024
- Primary completion date
- 28 Apr 2025
- Lead sponsor
- Fayoum University Hospital
- Diseases
- Glaucoma
- NCT number
- NCT06962384
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 1 May 2024 to the primary completion date, 28 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Orbital malignancy or suspected intraocular tumor
- Active ocular or periocular infection
- History of radiation therapy to the orbit
- Presence of autoimmune disease affecting wound healing
- Psychiatric disorders affecting compliance with postoperative care
Other
- Severe scleral thinning that contraindicates scleral preservation
Who the study is looking for
- Aged 18 years or older
- Indication for evisceration due to a non-malignant cause, such as painful blind eye, severe ocular trauma, end-stage glaucoma, or phthisis bulbi
- Adequate scleral integrity to allow for ball implantation
- No history of previous intraocular surgery or scleral weakening disorders
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fayoum University Hospital Coordinator of this site? Confirm its status | Al Fayyum | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.